Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation.
Europe Innovation
The start of 2019 has seen its fair share of interesting developments for the pharma industry.
Dual identities: Brexit and Europe's innovation drive
Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation.
Published:
|
2 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.